Oregon Public Employees Retirement Fund Has $6.36 Million Stock Holdings in CVS Health Co. (NYSE:CVS)

Oregon Public Employees Retirement Fund increased its stake in shares of CVS Health Co. (NYSE:CVS) by 0.2% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 107,762 shares of the pharmacy operator’s stock after buying an additional 220 shares during the period. Oregon Public Employees Retirement Fund’s holdings in CVS Health were worth $6,364,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Wedmont Private Capital raised its position in shares of CVS Health by 0.8% during the first quarter. Wedmont Private Capital now owns 19,225 shares of the pharmacy operator’s stock worth $1,410,000 after acquiring an additional 146 shares during the last quarter. Moody National Bank Trust Division raised its holdings in CVS Health by 0.7% during the 1st quarter. Moody National Bank Trust Division now owns 22,268 shares of the pharmacy operator’s stock worth $1,776,000 after purchasing an additional 150 shares during the last quarter. Landmark Financial Advisors LLC lifted its position in CVS Health by 3.8% during the 4th quarter. Landmark Financial Advisors LLC now owns 4,166 shares of the pharmacy operator’s stock valued at $329,000 after purchasing an additional 153 shares during the period. Garland Capital Management Inc. boosted its stake in shares of CVS Health by 0.3% in the 2nd quarter. Garland Capital Management Inc. now owns 60,810 shares of the pharmacy operator’s stock valued at $3,591,000 after purchasing an additional 160 shares during the last quarter. Finally, Sepio Capital LP grew its position in shares of CVS Health by 1.7% during the 4th quarter. Sepio Capital LP now owns 9,907 shares of the pharmacy operator’s stock worth $782,000 after buying an additional 163 shares during the period. Institutional investors own 80.66% of the company’s stock.

CVS Health Stock Performance

Shares of CVS Health stock opened at $59.30 on Thursday. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.86 and a quick ratio of 0.66. The firm has a market cap of $74.44 billion, a price-to-earnings ratio of 10.42, a price-to-earnings-growth ratio of 0.80 and a beta of 0.52. CVS Health Co. has a one year low of $52.77 and a one year high of $83.25. The stock’s 50-day moving average is $58.33 and its 200-day moving average is $64.04.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, topping analysts’ consensus estimates of $1.73 by $0.10. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The firm had revenue of $91.23 billion during the quarter, compared to the consensus estimate of $91.41 billion. During the same quarter in the prior year, the firm posted $2.21 EPS. The business’s revenue was up 2.6% on a year-over-year basis. Equities analysts predict that CVS Health Co. will post 6.52 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, August 1st. Shareholders of record on Monday, July 22nd were paid a $0.665 dividend. The ex-dividend date was Monday, July 22nd. This represents a $2.66 annualized dividend and a yield of 4.49%. CVS Health’s payout ratio is currently 46.75%.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on CVS shares. Argus cut their price objective on shares of CVS Health from $100.00 to $80.00 and set a “buy” rating on the stock in a report on Wednesday, May 8th. Robert W. Baird started coverage on CVS Health in a research report on Thursday, May 30th. They issued a “neutral” rating and a $61.00 price target on the stock. Cantor Fitzgerald reiterated a “neutral” rating and issued a $62.00 price objective on shares of CVS Health in a report on Monday, August 19th. Deutsche Bank Aktiengesellschaft decreased their target price on CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research report on Friday, August 9th. Finally, Evercore ISI cut their price target on shares of CVS Health from $65.00 to $62.00 and set an “outperform” rating on the stock in a research report on Thursday, August 8th. Eleven equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $72.48.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.